MANAGEMENT OF HYPERTENSION DURING THE COVID-19 PANDEMIC AND BEYOND – Part 2

Webinar Now Available – click here

European Society of Hypertension (ESH), the leading hypertension (HTN) society in Europe, presented an updated position paper on renal denervation (RDN) during the 8th pre-ESH congress satellite symposium in Athens, Greece from September 10-11, 2021 .

This position paper written by an ESH expert Working Group confirms that RDN is considered a safe endovascular procedure without significant short-term or long-term adverse effects based on data available up to three years.

Study of the European Society of Hypertension on Blood Pressure Control in ESH Excellence Centres
dedicated to Professor Alberto Zanchetti.

The most important task of the European Society of Hypertension is to improve blood pressure treatment and increase blood pressure control, thus decreasing cardiovascular risk, premature cardiovascular and renal morbidity and mortality, with in addition a reduction of health-care costs.

The goal is to establish a European sustainable and multidisciplinary network of internationally renowned members for blood pressure research in children and adolescents. The initiative conveys 21 countries across Europe and America in a global vision to promote wide networks of excellence in research.